abnormal long term potentiation_Stxbp5<tm1Ytk>/Stxbp5<tm1Ytk>

http://metadb.riken.jp/0002207I129X1SvJC57BLC57BL6DBAStxbp5tm1YtkStxbp5tm1YtkStxbp5tm1Ytk

abnormal long term potentiation_Stxbp5<tm1Ytk>/Stxbp5<tm1Ytk>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• syntaxin binding protein 5 (tomosyn)
  http://metadb.riken.jp/db/mgi_rdf/MGI:1926058

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Stxbp5<tm1Ytk>/Stxbp5<tm1Ytk>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Stxbp5<tm1Ytk>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * C57BL * C57BL/6 * DBA

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal long term potentiation
  http://purl.obolibrary.org/obo/MP_0002207

文献

http://purl.org/net/cito/citesAsAuthority

• Toshiaki. Sakisaka, et.al., Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release., The Journal of cell biology, 2008, 183
  http://rdf.ncbi.nlm.nih.gov/pubmed/18936251